Deals

Progenics Pharmaceuticals Closes $35M CMPO at 6% Discount via Jefferies, Needham, Brean

By |

Progenics Pharmaceuticals, Inc. (PGNX) announced that it has raised $35,000,002 in a CMPO/Overnight transaction. The common stock was sold at $4.60 per share, an approximate 6% discount to the market price ($4.90) of PGNX at deal announcement. Jefferies acted as the Sole Book-Runner with Needham & Company and Brean Capital acting as Co-Managers on the transaction. Underwriter counsel was Wilmer Cutler Pickering Hale & Dorr, LLP and issuer counsel was O'Melveny & Myers, LLP. Note this Placement is subject to customary closing conditions and is expected to close by 02/26/2014.

Deals

Solitario Exploration & Royalty Raises $1.7M at 30% Discount via Haywood Securities

By |

Solitario Exploration & Royalty Corporation (XPL) announced that it has raised $1,680,000 in a Common Stock transaction. The common stock was sold at $1.05 per share, an approximate 30% discount to the market price ($1.51) of XPL at deal announcement. Haywood Securities, Inc. acted as the exclusive agent on the transaction. The transaction is subject to the filing of additional listing applications with the NYSE MKT and the Toronto Stock Exchange. via PlacementTracker.

Deals

SMSA Crane SPAC Raises $3M via Pariter Securities to Finance Merger

By |

SMSA Crane Acquisition Corporation (SSCR) announced that it has raised $3,068,370 in a Common Stock transaction. The common stock was sold at $3.16 per share. Pariter Securities, LLC acted as the exclusive agent on the transaction. The transaction closed on February 14, 2014. Following completion of the required audit of Coquí Radio Pharmaceuticals Corporation it will merge into the Company, cancelling its shares of common stock of the Company and with the Company re-issuing the shares to Coqui’s shareholders.

Deals

Oculus Innovative Sciences Raises $1.35M in RDO at 24% Discount via Dawson James

By |

Oculus Innovative Sciences, Inc. (OCLS) announced that it has raised $1,351,860 in a Registered Direct transaction. The common stock was sold at $3.00 per share, an approximate 24% discount to the market price ($3.97) of OCLS at deal announcement. A series of 450,620 60-Month Warrants with an exercise price of $3.00 per share (24.43% discount) was issued to the investors in this transaction. An additional series of 1,400,000 18-Month Warrants with an exercise price of $3.63 per share (8.56% discount) was issued to the investors in this transaction. Dawson James Securities, Inc. acted as the exclusive agent on the transaction.